S-8 S-8 EX-FILING FEES 0001393434 OCULAR THERAPEUTIX, INC Fees to be Paid Fees to be Paid Fees to be Paid 0001393434 2025-06-11 2025-06-11 0001393434 1 2025-06-11 2025-06-11 0001393434 2 2025-06-11 2025-06-11 0001393434 3 2025-06-11 2025-06-11 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

OCULAR THERAPEUTIX, INC

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, $0.0001 par value per share Other 6,000,000 $ 8.29 $ 49,740,000.00 0.0001531 $ 7,615.19
2 Equity Common Stock, $0.0001 par value per share Other 2,750,000 $ 7.44 $ 20,460,000.00 0.0001531 $ 3,132.43
3 Equity Common Stock, $0.0001 par value per share Other 2,000,000 $ 8.29 $ 16,580,000.00 0.0001531 $ 2,538.40

Total Offering Amounts:

$ 86,780,000.00

$ 13,286.02

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 13,286.02

Offering Note

1

1(a) In accordance with Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. 1(b) Consists of 6,000,000 shares issuable under the 2021 Stock Incentive Plan, as amended (the "2021 Plan"). 1(c) The proposed maximum offering price per unit and maximum aggregate offering price are estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. They are calculated on the basis of the average of the high and low sale prices of the registrant's common stock on the Nasdaq Global Market on June 4, 2025, in accordance with Rule 457(c) under the Securities Act.

2

2(a) In accordance with Rule 416 under the Securities Act, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. 2(b) Consists of 2,750,000 shares subject to outstanding options granted by the registrant under the 2021 Plan, the commencement of vesting of which were conditioned upon the approval by the registrant's stockholders of an amendment to the 2021 Plan. 2(c) The proposed maximum offering price per unit and maximum aggregate offering price are estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act. They are calculated on the basis of $7.44, the exercise price of the shares subject to outstanding options.

3

3(a) In accordance with Rule 416 under the Securities Act, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. 3(b) Consists of 2,000,000 shares issuable under the Amended and Restated 2014 Employee Stock Purchase Plan. 3(c) The proposed maximum offering price per unit and maximum aggregate offering price are estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. They are calculated on the basis of the average of the high and low sale prices of the registrant's common stock on the Nasdaq Global Market on June 4, 2025, in accordance with Rule 457(c) under the Securities Act.